19.07

2.05% -0.40

Pre-market: 19.10 0.03 +0.16%

Schrodinger Inc (SDGR)

Overview News Price History Option Chain Financials Why SDGR Down? Discussions Forecast

Schrodinger Inc stock is traded at $19.07, with a volume of 686.54K. It is down -2.05% in the last 24 hours and down -8.45% over the past month. Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.

Previous Close:

$19.47

Open:

$19.62

24h Volume:

686.54K

Relative Volume:

1.01

Market Cap:

$1.39B

Revenue:

$188.48M

Net Income/Loss:

$-143.14M

P/E Ratio:

-9.5829

EPS:

-1.99

Net Cash Flow:

$-158.83M

1W Performance:

-9.83%

1M Performance:

-8.45%

6M Performance:

-14.87%

1Y Performance:

-32.85%

1-Day Range:

$18.62

$19.76

1-Week Range:

$18.20

$20.87

52-Week Range:

$16.67

$33.63

Schrodinger Inc Stock (SDGR) Company Profile

Name

Schrodinger Inc

Sector

Healthcare (1191)

Industry

Health Information Services (62)

Phone

503-299-1150

Address

1540 BROADWAY, NEW YORK, NY

Employee

787

Twitter

@schrodinger

Next Earnings Date

2024-11-12

Latest SEC Filings

SDGR's Discussions on Twitter

Compare SDGR with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SDGR Schrodinger Inc	19.07	1.39B	188.48M	-143.14M	-158.83M	-1.99
VEEV Veeva Systems Inc	210.86	34.23B	2.66B	665.91M	1.08B	4.05
SOLV Solventum Corp	70.19	12.13B	8.26B	66.00M	1.17B	0.3682
DOCS Doximity Inc	50.77	9.48B	516.85M	174.11M	217.38M	0.87
HQY Healthequity Inc	103.61	8.98B	1.15B	96.70M	-161.99M	1.09
WAY Waystar Holding Corp	37.36	6.43B	906.14M	-52.62M	89.62M	-0.3621

Schrodinger Inc Stock (SDGR) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-02-24	Initiated	Leerink Partners	Outperform
Dec-05-23	Initiated	KeyBanc Capital Markets	Overweight
May-05-23	Resumed	Piper Sandler	Overweight
Dec-19-22	Initiated	Goldman	Neutral
Mar-01-22	Initiated	Citigroup	Buy
Nov-19-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Nov-19-21	Initiated	Piper Sandler	Overweight
Nov-11-21	Downgrade	BofA Securities	Buy → Neutral
Oct-13-21	Initiated	Berenberg	Buy
Sep-01-21	Upgrade	Morgan Stanley	Equal-Weight → Overweight
May-25-21	Initiated	Craig Hallum	Buy
Nov-23-20	Upgrade	BofA Securities	Neutral → Buy
Oct-12-20	Upgrade	Jefferies	Hold → Buy
Mar-02-20	Initiated	BMO Capital Markets	Outperform
Mar-02-20	Initiated	Jefferies	Hold
Mar-02-20	Initiated	Morgan Stanley	Equal-Weight

View All

Schrodinger Inc Stock (SDGR) Latest News

Jan 14, 2025

Goldman Sachs maintains Schrodinger stock at Neutral By Investing.com - Investing.com Canada

Jan 14, 2025

Goldman Sachs maintains Schrodinger stock at Neutral - Investing.com India

Jan 14, 2025

Jan 13, 2025

Schrödinger Provides Update on Progress Across the Business and Outlines 2025 Strategic Priorities - Yahoo Finance

Jan 13, 2025

Jan 11, 2025

Schrödinger, Inc. (NASDAQ:SDGR) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

Jan 11, 2025

Jan 07, 2025

Barclays PLC Increases Stock Position in Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat

Dec 27, 2024

Dec 26, 2024

Jane Street Group LLC Has $1.80 Million Stock Position in Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat

Dec 26, 2024

Dec 21, 2024

State Street Corp Has $39.99 Million Stake in Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat

Dec 21, 2024

Dec 18, 2024

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)December 17, 2024 - BioSpace

Dec 18, 2024

Dec 17, 2024

Schrödinger Awards Inducement RSU Grants to New Employees Under 2021 Equity Plan - StockTitan

Dec 17, 2024

Schrödinger, Inc. (NASDAQ:SDGR) Receives $32.90 Consensus PT from Brokerages - MarketBeat

Dec 17, 2024

(SDGR) Investment Analysis and Advice - Stock Traders Daily

Dec 17, 2024

Dec 12, 2024

Biosimulation Industry Forecast, 2029: Analysis of Case Studies, Market Dynamics, Regional Growth Trends, Regulatory Landscape, Value Chain, and Competitive Intelligence - GlobeNewswire Inc.

Dec 12, 2024

Dec 06, 2024

How To Trade (SDGR) - Stock Traders Daily

Dec 06, 2024

Dec 05, 2024